Transcript Highlights:

• And because the treatments were only, you know, treating the amyloid build up, And because the treatments
• Those kinds of things, treatment of dementia.
• But treatments and diagnostics, the availability of them, are great.
• By that time, people become ineligible for treatment.
• But by that time, people become ineligible for treatment. Yeah.

Committee: All ALZHEIMER'S DISEASE AND DEMENTIA ADVISORY COUNCIL

Summary: The Arkansas Alzheimer’s Disease and Dementia Advisory Council met to introduce members, adopt its rules and procedures, approve prior minutes, and authorize the co-chairs to approve special expenses. The main discussion focused on updating the Arkansas State Plan for Alzheimer’s disease and dementia, with David Cook of the Alzheimer’s Association outlining major changes in prevalence, caregiving burden, diagnostics, and treatment since the prior plan. He noted rising disease and caregiver numbers in Arkansas, the expansion of amyloid PET access, the growing use of blood-based biomarkers, and the availability of FDA-approved treatments such as Leqembi and Kisunla, while emphasizing that access, insurance coverage, and provider education remain major barriers. Members and presenters also discussed the need to better reach rural primary care providers, who may not be aware of new diagnostics and therapies, and the bottlenecks caused by limited specialists and infusion capacity. There was concern about overreliance on blood tests without confirmatory evaluation, and several members stressed the importance of collaboration, public education, and promoting brain health through exercise and diet. The council also heard about existing programs such as the dementia services coordinator, the BOLD grant, caregiver respite grants, workforce training, and a pilot dementia resource center with UAMS Centers on Aging. The council approved a new four-part outline for the next state plan: advancing risk reduction and brain health/early detection, strengthening family caregiver support, improving access to diagnostics and treatment, and supporting access and quality of care, including workforce and crisis response. Members also agreed to consider future agenda items on new treatments, brain health and lifestyle prevention, workforce training, and possible legislative changes to the enabling statute. The meeting ended with discussion of scheduling the next meeting, tentatively set for August 12 in Hot Springs, and adjournment.

Transcript Highlights:

• </c> Ali one day Gavin received a treatment Ali one day Gavin received a treatment and<00:09:57.040><
• No treatment would help.
• MLD treatments we the world-renowned MLD treatments we need<00:15:50.959><c> the</c><00:15:51.120><c
• We know the treatment is working.
• We know the treatment is working.

Transcript Highlights:

• For veterans who have exhausted conventional treatments for PTSD, opioid use disorder, or treatment-resistant
• I do have a lot of familiarity with both treatments. I've undergone both treatments.
• I had pursued conventional medical treatments, but they did not provide the treatment that I needed or
• Is psilocybin a treatment that's done for—you mentioned six weeks—is that the usual course of treatment
• Is that the usual course of treatment?

Committee: House Emerging Issues

Transcript Highlights:

• coverage decisions, treatment guidelines, and policies when providing covered treatment to an injured
• Regarding reopening of claims and continued treatment...
• The treatment went on and on and on, and he recommended... The treatment went on and on and on.
• However, this policy limits treatment.
• However, this policy limits treatment.

Bills: HB2091 , HB2105 , HB2218 , HB2107 , HB2137 , HB2243 , HB2264

Committee: House Labor & Workplace Standards

Keywords: public employers, employee information, bargaining representatives, labor relations, union representation, immigrant worker protections, immigrant rights, worker protections, I-9 audit, Form I-9, employment eligibility verification, workplace raid, federal immigration inspection, employer notice, anti-retaliation, retaliation, Attorney General enforcement, private right of action, labor law, workplace rights

Transcript Highlights:

• Narcan and other treatments.
• It includes the substance use treatment community.
• settings and the willingness of people to stay in those treatment settings.
• Into the outreach and treatment section as well, you can correct me on that.
• or what might be preventing them or making them feel uneasy offering treatment.

Summary: The special commission on xylazine met virtually to review and discuss the first draft of its final report. Chair Mindy Domb opened the meeting, confirmed quorum, and the commission approved the minutes from its December 11 public meeting. Staff then walked commissioners through the proposed report structure, including background on xylazine as both an FDA-approved veterinary drug and an illicit drug supply contaminant, as well as appendices for public meeting materials and public resources. The commission discussed findings and recommendations for several working groups. For oversight and enforcement, members focused on licit versus illicit sources of xylazine, noting that the illicit supply is typically obtained through online vendors rather than diverted from veterinary use. Recommendations included better storage and reporting practices in authorized settings, review of manufacturing and distribution information, and focusing enforcement on fentanyl trafficking and large-scale xylazine importation rather than personal possession. Commissioners also discussed whether xylazine should remain in Schedule 6 or be subject to additional penalties, and several members emphasized the need for coordination, information-sharing, and possibly a DPH task force or advisory body to monitor emerging drug threats. For outreach and treatment, staff summarized strong existing programs such as drug checking, wound care education, naloxone distribution, mobile and low-threshold care, and self-directed wound kits, while noting gaps including the lack of an FDA-approved reversal agent for xylazine, difficulty distinguishing xylazine from other exposures, and uneven access by geography, insurance, and audience. Commissioners stressed the need for provider education, including physicians, nurses, pharmacists, family support networks, and first responders, and for clear guidance on wound care and when more intensive treatment is needed. The education and training section identified first responders, clinicians, non-clinicians, and people who use drugs and their families as key audiences for tailored, stigma-free materials, with emphasis on real-time, centralized data, naloxone and breathing support, recognition of overdose versus xylazine exposure, and adapting materials as the drug supply changes. The meeting ended with discussion of next steps: staff will circulate a revised draft by March 2, the commission will meet again on March 9 to consider the report and recommendations, and an additional late-March meeting was reserved if needed before the statutory deadline.

Transcript Highlights:

• the treatment court.
• the treatment court.
• Not all counties or circuits have a treatment court commissioner or treatment court administrator.
• nor a treatment court commissioner.
• court for the treatment court judge.

Committee: House Corrections and Public Institutions

Summary: The committee first called the roll and established a quorum with nine members present. It then moved into executive session and took up House Committee Resolution 29, which was approved unanimously on a 9-0 roll call vote. Next, the committee considered House Bill 2414. After a brief motion and no discussion, the bill was voted do pass by a 6-3 roll call, with Chairman Mayhew, Vice Chair Cook, Representatives Davis, Dolan, Elliott, Faulkner, and Hovis voting yes, and Representatives Brown, Bush, and Kalberloh voting no. The committee then took up Senate Bill 945. Members adopted House Committee Substitute 0.04C, then adopted two amendments: one concerning the sheriff’s attorney fee language and another concerning treatment court administration and reimbursement. After rolling the amendments into a new substitute, the House Committee Substitute for Senate Bill 945 was voted do pass by a 9-1 roll call vote, and the committee adjourned.

Transcript Highlights:

• treatment.
• , that they can sustain their treatment, and then that treatment can transition to the communities.
• Isolation is not treatment.
• What we call assisted outpatient treatment in our statute is not like the assisted outpatient treatment
• And they are being evicted from their treatment homes.

Summary: The joint Senate and House Behavioral Health committee met for informational presentations on the Oregon State Hospital and civil commitment, followed by a planned tour of the hospital. Oregon Health Authority and Oregon State Hospital leaders reported that Sean Murphy will become the next permanent superintendent on July 13, with Sarah Castle to follow as permanent chief nursing officer on July 20. They described recent leadership turnover, a major organizational restructure, and efforts to build a culture of safety, transparency, and accountability. Officials said the hospital regained Joint Commission accreditation and CMS compliance, and they highlighted daily safety huddles, incident review processes, stronger escalation procedures, and improved management of seclusion and restraint. Committee members pressed hospital leaders on past prolonged seclusion practices, falls, staffing, and the need for better public reporting; OHA said it is building a public dashboard of key safety and workforce metrics. The committee then heard a civil commitment overview from the Oregon Judicial Department. The presenter explained that civil commitment is a separate legal process from criminal cases, usually beginning with a hospital hold, investigation, court review, appointed counsel, and a hearing within five days. She summarized changes made in House Bill 2005, including revised standards for danger to self, danger to others, and basic-needs commitments, plus a second 14-day diversion option. She cautioned that the new law has only been in effect since January and that it is too early to draw firm conclusions from the data, though there has been a recent uptick in commitments and a decrease in diversions. Testimony from NAMI Oregon and a forensic psychiatrist emphasized that Oregon still relies too heavily on jails and state hospitals because community services, housing, and outpatient supports are insufficient. They argued that the state needs more less-restrictive alternatives, including better use of assisted outpatient treatment or outpatient civil commitment, and more supported housing so people do not cycle between homelessness, incarceration, and hospitalization. A family member described a relative remaining psychotic in jail for more than 120 days before ending up back at the state hospital, urging faster intervention and better collaboration among courts, counties, hospitals, and state agencies. Committee members and witnesses also discussed workforce shortages, the expansion of secure residential treatment beds, and the need for broader system reforms beyond the hospital itself.

Transcript Highlights:

• So, iatrogenic, which just means it was induced by our treatment.
• I have done three treatments. I have five left.
• It's something that the treatment that they have... ...inflicted.
• Essentially, it's a side effect of their treatment.
• I know, because I've had to go through the same type of treatment.

Committee: House Health and Welfare

Transcript Highlights:

• And these treatment plans are really important because they define treatment goals and objectives.
• Is this treatment, is a difference, like their location?
• And they're providing an intensive kind of inpatient treatment.
• This is how individuals will now receive treatment in a supervised treatment program in the community
• They have completed their treatment program and the court has ordered them to outpatient treatment status

Summary: The Joint Legislative Audit Committee held an oversight hearing on the state auditor’s October 2024 report on California’s Forensic Conditional Release Program (CONREP) for sexually violent predators. Members and witnesses discussed public safety, the long delays in finding community housing, the role of local housing committees, and the Department of State Hospitals’ oversight of Liberty Healthcare, which operates much of the program. Several legislators from rural and high-desert districts said their communities have been disproportionately affected by placements and questioned why many placements end up in remote areas. State Auditor Grant Parks said the audit found that CONREP participants were convicted of new offenses less often than sexually violent predators who were unconditionally released, but that 18 of 56 participants had been revoked and returned to state hospitals for noncompliance. He said it took an average of 17 months to place current participants in the community, with 20 additional people awaiting placement for an average of 20 months, and that the program incurred significant pre-placement costs. Parks also said local officials were often unclear about their role, DSH had not given clear guidance at the time of the audit, and California lacks a transitional housing option used in some other states. He reported that DSH had implemented four of the five audit recommendations, while declining the recommendation to explore state-owned transitional housing. DSH Director Stephanie Clendendon and Liberty representative Ken Carabello defended the program as a court-ordered, highly supervised treatment model intended to reduce reoffending and support reintegration. They said DSH is actively involved in placement review, that Liberty searches countywide under statutory restrictions, and that community feedback and court approval are part of the process. DSH said it has now implemented guidance for housing committee designees, formal program reviews, an outcome tracker, and an analysis of whether to separate some Liberty services into different contracts. DSH continued to oppose transitional housing, arguing it would not solve the core siting and statutory problems and would add cost. Several members remained critical, arguing the program is broken, costly, and unfairly concentrated in certain communities, and some called for major statutory changes or suspension of the program.

Transcript Highlights:

• Effective outreach and treatment programs for patients who have been exposed to xylazine and ways to
• address any gaps that might exist in available outreach and treatment programs and services.
• Representative, I think one thing to also think about is treatment.
• Kimmel have any thoughts about those treatment pieces.
• The treatment and the education.

Summary: The Working Group on Outreach and Treatment of the Special Commission on Xylazine held its first meeting, chaired by Gabe Adams-Cain in Senator John Villis’s absence. Members introduced themselves and described priorities such as improving education about xylazine, expanding first responder and clinical training, and ensuring patients and providers know how to respond to xylazine-related wounds and complications. Several participants emphasized that outreach should reach both people who have not been exposed and those already affected, and that stigma is a major barrier for patients and families. Discussion focused on the main challenges to treatment and outreach, including limited awareness, inconsistent wound care access, gaps in geographic coverage, cost of supplies, and the need for better training in both outpatient and inpatient settings. Dr. Kimmel noted that harm reduction and outreach programs are already providing much of the care, but often lack specialized staff, sufficient supplies, and standardized protocols. He also said xylazine can complicate withdrawal and make it harder for people to engage in substance use treatment. Members discussed the value of non-stigmatizing, consensus messaging, family support organizations, and existing resources such as PARI, StreetCheck, and state-funded syringe service and naloxone networks. The group also reviewed the commission timeline and next steps. Staff said materials for the December 11 full commission meeting should be submitted by December 2, with draft presentation materials to be shared by December 4 and reviewed by December 9. Members agreed to do additional follow-up research on topics including the cost-effectiveness and contents of self-care wound kits, outreach to family and recovery organizations, incarcerated populations, and geographic access gaps. The meeting ended with agreement to use a PowerPoint-style presentation and to continue compiling research through a shared folder, followed by adjournment at 9:55 a.m.

Transcript Highlights:

• coverage decisions, treatment guidelines, and policies when providing covered treatment to an injured
• The treatment went on and on and on.
• Treatment guidelines are designed to work for most cases.
• However, this policy limits treatment.
• However, this policy limits treatment.

Summary: The committee first took up House Bill 2091, a collective bargaining measure that would require state agencies and other employers covered by the Personnel System Reform Act to provide unions with employee contact and job information similar to what other public employers already must share. The sponsor and union witnesses said the bill would close a gap left by prior legislation and improve communication with represented employees; no one testified in opposition during the hearing portion shown. Action on the bill was deferred. The committee then moved to House Bill 2264, which would allow workers who voluntarily participate in an employer-initiated layoff or reduction-in-force plan to qualify for unemployment insurance if the separation results from that plan. The sponsor and a member described it as a narrow fix to clarify eligibility and reduce disputes. After brief supportive testimony, the committee voted 9-0 to report the bill out with a due pass recommendation. A lengthy hearing followed on House Bill 2218, a workers’ compensation bill that would expand provider choice, require notice to injured workers of their right to choose a provider, limit employer steering, speed utilization review, allow more flexibility from treatment guidelines, and change rules for reopening or continuing treatment on certain claims. Supporters, including injured workers, unions, attorneys, firefighters, and a psychiatrist, argued the current system delays care and over-relies on rigid guidelines; opponents from business groups and the Department of Labor and Industries said the bill would weaken evidence-based standards, raise costs, and create uncertainty. No final action was taken in the portion shown. The committee also heard House Bill 2105, as a proposed substitute, which would require employers to notify workers after an ICE Form I-9 inspection notice or results, limit voluntary access to certain records without a subpoena or warrant, require workplace postings, and create enforcement by the Attorney General and private lawsuits. Supporters said the bill would provide due process, transparency, and protection for immigrant workers; opponents, especially small business and agricultural groups, warned of conflicts with federal law, burdensome notice requirements, and severe penalties. The hearing continued with additional testimony, and no vote was taken in the excerpt provided.

Transcript Highlights:

• Treatment is excruciating and expensive.
• So two years in custody could include mental health treatment, substance abuse treatment, whatever that
• There's no mandated mental health treatment.
• for an actual person who needs that treatment.
• There's no mandated mental health treatment here.

Bills: S0132 , S0418 , S0442 , S0646 , S0748 , S1326 , S1332 , S1660 , S1734 , S1742 , S1750

Committee: Senate Criminal Justice

Summary: The committee took up a series of criminal justice and public safety bills. SB 646, allowing the use of drug testing tools such as fentanyl test strips and reagent kits to detect dangerous adulterants, was presented as a harm-reduction measure and reported favorably after supportive testimony from advocates and criminal defense groups. SB 442, extending the return period for warrants involving digital evidence from 45 days to one year, also passed unanimously amid testimony from prosecutors and law enforcement about encryption, backlogs, and large volumes of child exploitation evidence. SB 418, creating autism-related law enforcement training and a Blue Envelope Program for traffic stops and other encounters, was reported favorably with support from police, disability advocates, and families. SB 132, creating a public database to help people determine eligibility for restoration of voting rights, and SB 748, requiring notice of voting-rights restoration information on sentencing score sheets, both passed with broad support from voting-rights and criminal defense advocates. The committee also approved SB 1734, recognizing juvenile probation and detention officers as officers under Florida law and extending related training and benefits, and SB 1660, designating June as Responsible Firearm Safety Awareness Month. SB 1742, which repealed the existing “unnatural and lascivious acts” statute and created a new offense for indecent exposure of sexual organs to a minor, was amended with a delete-all amendment and then reported favorably. SB 1750, a major overhaul of career offender registration requirements, was later reconsidered after a bill-number mix-up and then reported favorably as SB 1332, with FDLE and sheriff’s association support. The most contentious measure was SB 1326, which would eliminate the traditional insanity defense and replace it with a lack-of-culpable-mental-state defense, require malingering assessments in competency evaluations, and limit downward departures based on mental illness. Criminal defense attorneys and disability advocates argued it lacked a treatment component, raised scientific and cost concerns, and could worsen public safety by sending mentally ill defendants to prison without adequate care. Supporters, including the sponsor and the Attorney General’s office, argued it would close gaps and better protect the public. After extensive debate, the bill was reported favorably on a divided vote, with several members voting no. At the end of the meeting, members recorded additional votes on some bills, and Senator Pizzo moved for reconsideration of SB 1326 for a future meeting.

Transcript Highlights:

• The treatment worked. And it provided lifesaving treatment.
• The treatment worked. And it provided lifesaving treatment.
• The treatment worked. And it provided lifesaving treatment.
• The treatment worked. And it provided lifesaving treatment.
• </c> just to get their prescribed treatment. just to get their prescribed treatment.

Transcript Highlights:

• , the targeted pinpoint treatment for cancer treatments, and even in areas such as Alzheimer's and dementia
• , the targeted pinpoint treatment for cancer treatments, and even in areas such as Alzheimer's and dementia
• and get them to that treatment plan faster.
• The next step was radioactive iodine treatment, which is where biomarkers come into my treatment plan
• . ...identified for effective personalized treatment.

Committee: Joint Joint Committee on Financial Services

Summary: The Joint Committee on Financial Services held a lengthy public hearing with testimony on a wide range of health insurance and access-to-care bills. Early testimony focused on prescription drug pricing and pharmacy reimbursement, with supporters of H. 1326 arguing that pharmacy benefit managers and MassHealth managed care arrangements reimburse independent pharmacies too little, contributing to pharmacy closures and “pharmacy deserts.” The committee also heard repeated support for H. 1151/S. 742 on cognitive rehabilitation for acquired brain injury, H. 1288/S. 716 on telehealth parity for nutrition counseling, H. 1309/S. 761 on full-spectrum pregnancy care without cost-sharing, H. 1312 on insurance coverage for doula services, H. 309 on prompt access to health care by removing deductibles for certain services, H. 809/H. 1227 on biomarker testing, H. 1162/S. 810 on reducing inequities in access to medical procedures by limiting insurer cuts tied to Modifier 25, and S. 726 on insurance coverage for mobile integrated health. Testifiers included legislators, physicians, pharmacists, dietitians, emergency and rehabilitation clinicians, and patients and family members. Supporters of the brain injury bill said cognitive rehabilitation is medically necessary, improves long-term outcomes, and can reduce institutional care and public costs; they noted the bill has been heard repeatedly and has support from the Brain Injury Commission and prior favorable committee action. Supporters of the pregnancy care and doula bills described out-of-pocket costs as a barrier to maternal health and shared personal stories of high bills and unmet support needs. Biomarker testing advocates and cancer patients said coverage gaps deny patients access to precision treatment, can lead to avoidable suffering, and should be standardized across insurers; several speakers said insurers often deny claims despite clinical benefit. Dermatology witnesses said insurers’ use of Modifier 25 cuts reimbursement for same-day evaluation and procedure visits, forcing separate appointments and increasing patient burden. Mobile integrated health supporters described home-based care as a way to reduce emergency department use and hospital readmissions, especially for patients with transportation or mobility barriers. No votes or formal committee actions were taken during the hearing itself.

Transcript Highlights:

• , and opioid treatment programs.
• </c> and day Treatment and day Treatment Services<00:36:32.680><c> um</c><00:36:32.920><c> Children's
• </c> the compulsive gambling treatment the compulsive gambling treatment program<00:36:45.280><c> and
• </c> licensed treatment licensed treatment facilities<00:37:24.480><c> um</c><00:37:24.880><c> this</
• plans treatment and individual treatment plans treatment and medical<00:37:34.480><c> services</c><00

Committee: House Human Services Finance and Policy

Transcript Highlights:

• offender treatment provider.
• ' treatment team.
• I mean, it says that the property owner provides the supervision and treatment or monitoring and treatment
• and treatment.
• treatment.

Bills: SB6339 , SB6184 , SB6224 , SB6255 , SB5977 , SB5979 , SB6249 , SB6007 , SB6186 , SGA9299

Committee: Senate Human Services

Keywords: alternative placements, individual ownership, restrictive policies, healthcare, operational control, homeless youth, youth services, mental health, support programs, state law, behavioral health, children, support services, poverty reduction, intergenerational poverty, WorkFirst, Temporary Assistance for Needy Families, TANF, self-sufficiency, economic justice

Transcript Highlights:

• We will next go to a medication-assisted treatment.
• For those who are uninsured and cannot afford treatment, Seven people have received treatment since the
• Health offices for treatment.
• Awareness strategies to support alcohol use disorder treatment expansion.
• Within their treatment, where were they referred?

Committee: House Legislative Health & Human Services Committee

Transcript Highlights:

• </c> to go to treatment. to go to treatment.
• ,</c><00:32:37.440><c> the</c> Several weeks into his treatment, the Several weeks into his treatment
• Just by ways of into treatment.
• </c> anybody not getting to the treatment anybody not getting to the treatment program.<00:57:38.880>
• </c> the treatment providers in one place. the treatment providers in one place.

Summary: The Budget Review Subcommittee on Justice and Judiciary heard testimony from the Department of Public Advocacy (DPA) on attorney compensation and alternatives to incarceration. Because the committee lacked a quorum, the chair skipped formal roll call and minutes approval, then invited DPA Public Advocate Damon Preston, Deputy Public Advocate Melanie Lowe, and alternative sentencing worker Cena/Tina Mills to present. Preston said DPA is fully state-funded, has 698 funded positions, and was near full staffing with 673 filled positions and 42 new law graduates expected to join in August. He argued that DPA’s resources lag behind those of prosecutors, noting that local prosecutorial offices receive substantially more total funding and have additional revenue sources beyond the state budget. Preston focused on salary disparities and turnover. He said DPA trial-office attorneys total about $26 million in salaries, compared with about $41.9 million for prosecutors on publicly listed state funding, and estimated that more than 100 additional prosecutors are paid through other sources, bringing total prosecutor compensation to a little over $50 million versus DPA’s $26 million. He said starting DPA attorney pay is $58,200, experienced attorney pay averages about $73,000, and that these levels are too low given law school debt and the state’s constitutional obligation to provide defense counsel. He also said DPA attorney turnover is about 20%, median service time before separation was 15 months in 2024, and exit interviews often cite salary as the main reason for leaving. He gave examples of former DPA attorneys moving to prosecutor offices for raises ranging from 12% to 50%. Committee members asked about how often defendants are represented by private counsel versus DPA and how that affects workload. Preston said a 2017 study found about 50% of misdemeanor cases and about 75% of circuit court cases were handled by DPA, with DPA handling most of the most labor-intensive cases. He said DPA will step aside when a defendant hires private counsel or is found ineligible, and he acknowledged the system historically erred by denying counsel in some cases, though he said the current concern is whether DPA is now appointed too broadly. Members requested updated trend data on appointments over the past decade. Preston also described DPA’s pay scale and said the agency’s compensation structure makes retention difficult. Mills then described DPA’s alternative sentencing worker program, which she said has operated for about 20 years and has received national recognition. She shared a case example involving a client named Patrick, who faced a prison sentence on a possession charge and was referred to a horse-based treatment and certification program in Shelbyville. She said the client wanted treatment and a fresh start, a bed became available, and she and the client’s attorney presented an alternative sentencing plan to the court. The presentation was interrupted briefly by a technical issue, but the testimony continued.

Transcript Highlights:

• If somebody's ordered to do treatment, whether substance abuse or any other treatment I'm going to talk
• The next two treatments...
• The last treatment I'll talk about is mental health treatment. And Dr. Klein...
• The last treatment I'll talk about is mental health treatment, and Dr.
• This treatment is a little bit different than the treatments I've talked about.

Summary: The Justice Budget Committee heard detailed presentations from the Department of Juvenile Justice and the Department of Corrections on staffing, services, and budget needs. DJJ Secretary Hall emphasized that the agency’s main public safety strategy is education, along with prevention and recidivism reduction. He described major staffing improvements after pay increases for probation, detention, residential care, and prevention workers, and outlined DJJ’s mental health, aftercare, and education continuum, including the Florida Scholars Academy and Florida Youth College. He said the new statewide education model is showing early gains in progress monitoring, high school graduation, and postsecondary enrollment, while also noting ongoing operational issues such as IT connectivity, rural staffing gaps, and the need for geographic pay adjustments for teachers. He also discussed detention center replacement plans in Hillsborough, Broward, and Palm Beach, and said DJJ would transition the Broward JAC to a security contractor after the sheriff’s office pulls sworn officers from the site. Members asked about campus performance differences, teacher pay, detention education quality, and concerns about the rollout and leadership of the Scholars Academy. Hall said some campuses face rural access and infrastructure problems, but the blended learning model provides continuity when internet or staffing issues arise. He defended the superintendent’s qualifications and said early problems with inappropriate online content were addressed. Representative Porras raised concerns about educational quality and the superintendent’s past disciplinary history, while Representative Barrera urged more mentorship and fatherhood-focused programming in juvenile facilities. DOC Secretary Dixon said the prison system is under pressure from rising inmate populations, staffing shortages, and overtime costs. He argued that the system needs funded posts for every functioning housing unit, noting that the department has added housing units without enough staff and now relies heavily on overtime, mobile officer deployments, and shift conversions to keep facilities operating safely. He highlighted that many officers are new, that outside-hospital transports have risen sharply, and that mental health units require additional staffing. DOC’s mental health chief described a large and growing treatment system with outpatient, inpatient, intensive outpatient, and court-ordered services, saying about a quarter of the prison population has a diagnosed mental illness. Community corrections staff described treatment programs, employment specialists, mobile probation and reentry units, and a new mental health first aid training initiative. Reentry staff reported expanded substance abuse, education, CTE, chaplaincy, and digital learning programs, including Edovo and a forthcoming Work Bay platform. No votes were taken.

Transcript Highlights:

• Gender-affirming medical care is not experimental, it's not elective, and it's not cosmetic treatment
• Gender-affirming medical care is not experimental, it's not elective, and it's not cosmetic treatment
• Gender-affirming medical care is not experimental, it's not elective, and it's not cosmetic treatment
• Hormone treatment has been life-saving.
• Those weeks without medical treatment were an absolute nightmare.

Summary: The committee first considered Senate Bill 2, sponsored by Senator Mike Wilson, which would prohibit incarcerated people from receiving cross-sex hormones or gender-affirming surgeries, while allowing a tapering period if stopping an existing treatment would cause physical harm. Wilson said the bill was needed to prevent the Department of Corrections from providing such care by memo or policy rather than statute, and he argued the care was elective and not medically necessary. Senators Thomas, Neal, Nemes, Styers, and others questioned whether any gender-affirming surgeries had actually occurred in Kentucky, whether the hormone treatments were physician-prescribed, and whether the bill would override medical judgment; Wilson said the department reported no surgeries, that 67 incarcerated people were receiving cross-sex hormone therapy, and that he would only support treatment if it fit the bill’s narrow medical-harm exception. Public testimony on SB 2 was strongly opposed. Chris Hartman of the Fairness Campaign said the bill would deny medically necessary care, violate the Eighth Amendment, and target a very small and vulnerable incarcerated population. Dr. Jack Skilles testified that gender-affirming care is medically necessary and supported by major medical organizations, warning that denying it could worsen mental health and lead to suicidality. Hannah Callahan, a transgender woman, described being denied hormone therapy while incarcerated and said the interruption caused severe physical and mental harm, including suicidal thoughts. Emma Curtis, Lexington’s Fourth District councilwoman, also urged a no vote, framing the issue as a matter of compassion and religious duty. The committee then voted on SB 2. Senator Neal explained his no vote by saying he was not medically trained and deferred to doctors; Senator Nemes said he wanted clarification that the bill would not stop ongoing treatment; and Senator Styers argued the bill was a poor priority and noted there was no fiscal note and that only 67 people were affected. Senator Wheeler moved the bill, Senator Reed seconded, and the committee reported Senate Bill 2 favorably. Afterward, the committee began hearing Senate Bill 84, sponsored by Senator Steve Rawlings, which would limit judicial deference to state agency interpretations and require courts, not agencies, to interpret ambiguous laws, citing the U.S. Supreme Court’s 2024 Loper Bright decision overturning Chevron deference.